Insulin receptor substrate-1 (IRS-1) was recently identified as a novel upstream substrate for the insulin-activated protein kinase C (PKC)-. This interaction down-regulates insulin signal transduction under hyper-insulinemic conditions. To clarify the molecular mechanism of this feedback loop, we sought to identify the PKC-phosphorylation sites of IRS-1 and to investigate their biological significance. Insulin resistance is associated with a variety of physiological and patho-physiological states, including type 2 diabetes, hypertension, glucose intolerance, and obesity; however, the molecular mechanisms that modulate insulin signaling under these conditions are difficult to resolve. One important early site of divergence in insulin signaling, which seems to be a relevant target for modulation of the signal, is insulin receptor substrate 1 (IRS-1) 1 (1). IRS-1 is a hydrophilic protein with an apparent molecular mass of 180 kDa containing a conserved pleckstrin homology domain located at the amino terminus, adjacent to a phosphotyrosine binding (PTB) domain (2). After insulin-stimulation, this domain interacts with the activated insulin receptor (IR), IRS-1 is subsequently tyrosine-phosphorylated, and the signal is transmitted further (1, 2). In addition to tyrosine phosphorylation, IRS-1 undergoes Ser/Thr phosphorylation at multiple sites (3, 4). Many in vitro and in vivo studies (5-13) have shown that increased Ser/Thr phosphorylation of IRS-1, e.g. after treatment of cells with either activators of protein kinase C (PKC), Ser/Thr phosphatase inhibitors, high insulin concentrations, or activation of cellular stress pathways by tumor necrosis factor ␣ and other cytokines, inhibits the IR-mediated tyrosine phosphorylation of IRS-1, thereby affecting insulin signal transduction.
Insulin resistance is associated with a variety of physiological and patho-physiological states, including type 2 diabetes, hypertension, glucose intolerance, and obesity; however, the molecular mechanisms that modulate insulin signaling under these conditions are difficult to resolve. One important early site of divergence in insulin signaling, which seems to be a relevant target for modulation of the signal, is insulin receptor substrate 1 (IRS-1) 1 (1) . IRS-1 is a hydrophilic protein with an apparent molecular mass of 180 kDa containing a conserved pleckstrin homology domain located at the amino terminus, adjacent to a phosphotyrosine binding (PTB) domain (2) . After insulin-stimulation, this domain interacts with the activated insulin receptor (IR), IRS-1 is subsequently tyrosine-phosphorylated, and the signal is transmitted further (1, 2) . In addition to tyrosine phosphorylation, IRS-1 undergoes Ser/Thr phosphorylation at multiple sites (3, 4) . Many in vitro and in vivo studies (5) (6) (7) (8) (9) (10) (11) (12) (13) have shown that increased Ser/Thr phosphorylation of IRS-1, e.g. after treatment of cells with either activators of protein kinase C (PKC), Ser/Thr phosphatase inhibitors, high insulin concentrations, or activation of cellular stress pathways by tumor necrosis factor ␣ and other cytokines, inhibits the IR-mediated tyrosine phosphorylation of IRS-1, thereby affecting insulin signal transduction.
The atypical PKC-, which is activated by insulin, has been identified to transduce insulin signaling downstream from IRS-1 and phosphatidylinositol 3-kinase in mediating glucose uptake. However, as reported recently, prolonged insulin stimulation of PKC-can also participate in the negative regulation of insulin signaling by phosphorylating IRS-1 at serine residues, as shown in Fao cells (6) and in NIH3T3 cells stably expressing the insulin receptor (8) . The PKC--mediated IRS-1 phosphorylation inhibits both IRS-1 interaction with the IR and the ability of insulin to phosphorylate IRS-1 on tyrosine residues.
We aimed to identify and characterize the functionally relevant Ser/Thr sites of IRS-1 responsible for the PKC--mediated attenuation of insulin signaling. Based on our novel previously described mass spectrometric procedure for phosphopeptide screening (14) , we identified Ser 318 as the major site phosphorylated by PKC-. Using polyclonal phospho-site-specific antibodies, we demonstrated that this site is also phosphorylated by PKC-in cellular extracts. The functional relevance of the phosphorylation site was studied by mutation of Ser 318 3 Ala (S318A). Our results indicate that PKC-promotes, at least partially, the phosphorylation of Ser 318 and suggest that this phosphorylation of Ser 318 might mediate the inhibitory effects of PKC-on the first steps of insulin signal transduction, i.e. the complex formation between IR and IRS-1 and the tyrosine phosphorylation of IRS-1 under prolonged insulin stimulation. ase inhibitor mixture was purchased from Roche (Mannheim, Germany), phosphatase inhibitors were obtained from Sigma (Munich, Germany), protein G-Sepharose CL-4B and 32 P-ATP were purchased from Amersham Biosciences (Freiburg, Germany), antibodies against the ␤-subunit of the IR (sc711) and IRS-1 (sc560) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), the antibodies against phospho-Tyr (4G10) and IRS-2 (06 -506) were purchased from Upstate Biotechnology (Lake Placid, NY), and the monoclonal anti-IRS-1 antibody (12H8) was made by NanoTools (Teningen, Germany). The pSer 307 -antibody was a kind gift from M. F. White (Harvard Univ., Boston, MA), and baby hamster kidney cells stably expressing the human insulin receptor (BHK IR ) were kindly provided by N. P. Møller (Novo Nordisk, Bagsvaerd, Denmark). Polyclonal anti-pSer 318 antiserum was raised against a synthetic peptide (SMVGGKPGpS-FRVRASSD) flanking Ser 318 in IRS-1 (which is conserved among mouse, rat, and human). Polyclonal anti-IRS-2 antiserum for IRS-2 immunoprecipitation was raised in rabbits against a synthetic peptide of the C-terminal part of mouse IRS-2. The recombinant human PKCwas purchased from Calbiochem (San Diego, CA). The cytomegalovirus promoter-based expression vectors for the rat IRS-1 and the human PKC-are described in Ref. 5 . All high-performance liquid chromatography (HPLC)-grade solvents were obtained from Merck (Darmstadt, Germany).
EXPERIMENTAL PROCEDURES

Materials-Cell
Purification and in Vitro Phosphorylation of GST-IRS-1 with PKC--The N-terminal, middle, and C-terminal portions of rat IRS-1 protein were generated as described (7) . In brief, the fragments were ligated to glutathione S-transferase and cloned into the pGEX-2T vector (Amersham Biosciences, Freiburg, Germany). The DNAs encoding these regions of IRS-1 were synthesized by PCR using rat IRS-1 cDNA as template and pairs of oligonucleotide primers that contained appropriate restriction sites bordering these fragments (15) . Because of a low expression level, the N-terminal fragment was subcloned into two smaller fragments. Altogether, the following four constructs were generated: IRS-1 N1 , amino acid residues 2-304, size 60.6 kDa; IRS-1 N2 , amino acid residues 265-522, size 53.8 kDa; IRS-1 M , amino acid residues 526 -859, size 62.6 kDa; IRS-1 C , amino acid residues 900 -1235, size 61.8 kDa (IRS-1 M and IRS-1 C were kindly provided by X. J. Sun, Burlington, VT). The PCR products were isolated, digested with appropriate restriction enzymes, and subcloned into pGEX-2T, which were used to transform E. coli BL 21. The fusion proteins were expressed and purified by affinity chromatography. The assays were performed at 30°C for 90 min with 25 pmol of the isolated GST-IRS-1 protein fragments, which was phosphorylated in vitro by 10 milliunits of PKC-in 55 mM HEPES-NaOH, pH 7.5, 1.25 mM EGTA, 1 mM EDTA, 5 mM MgCl 2 , 1 mM dithiothreitol, 10 M ATP, and 1 Ci of ␥-32 P-ATP. The samples were analyzed by SDS-7.5% PAGE and visualized by autoradiography.
In-gel Digestion-The GST-IRS-1 N2 -band at 54 kDa was excised and in-gel-digested as described elsewhere (14) . The resulting peptides were separated using a Shimadzu HPLC-system with a C2/C18, 100 ϫ 21-mm column (Amersham Biosciences); Detection was as follows: UV at ϭ 214 nm; flow rate ϭ 0.1 ml/min; buffer A, 0.05% trifluoroacetic acid in water (v/v); buffer B, 80% acetonitrile/0.05% trifluoroacetic acid (v/v); gradient, 0% buffer B (10 min), 10% buffer B (20 min), 40% buffer B (60 min), 100% buffer B (90 min), and return to 0% buffer B in 6 min. The collected fractions were analyzed in a Trilux 1450 MicroBeta Plus ␤-counter (PerkinElmer/Wallac, Turku, Finland).
Site-directed Mutagenesis-Mutation of S318A was made by oligonucleotide-mediated mutagenesis. The mutagenic upstream primer used was GGTGGGAAACCAGGTGCCTTCAGGGTGCGTGCC, with the wild-type IRS-1 expression vector serving as template. Positive clones were verified by sequencing.
Transfection, Cell Lysis, and Immunoprecipitation-BHK IR cells were cultured in Dulbecco's modified Eagle's medium containing 25 mM glucose, 10% fetal calf serum, 2 mM glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin. A minimum of 4.0 ϫ 10 5 cells/well of a six-well plate were transfected using the Ca 3 (PO 4 ) 2 -DNA coprecipitation method (16) . After incubation overnight at 37°C in 5% CO 2 , the cells were starved in Dulbecco's modified Eagle's medium (5.5 mM glucose) without fetal calf serum for 24 h and then stimulated with 32 P]ATP. The total assay sample amount was separated by SDS-7.5% PAGE and visualized by autoradiography. B, densitometric evaluation of the autoradiograms (n ϭ 3). C, 32 P-Cerenkov elution pattern generated by HPLC separation of tryptic peptides from wild-type GST-IRS-1 N2 phosphorylated by PKC-(solid line) in comparison to the S318A-GST-IRS-1 N2 point mutant after a PKCin vitro assay (dashed line).
insulin (100 nM) as indicated. Cells were lysed with 200 l of lysis buffer/well (50 mM Tris, pH 7.6, 150 mM NaCl, 1% Triton X-100, containing protease inhibitors and phosphatase inhibitors). Total protein (400 g) was used for immunoprecipitation. Immunoprecipitated proteins or 20 g of protein of the total extracts were separated by SDS-7.5% PAGE, and Western blot analysis was performed as described (5) .
Statistical Analysis-All data are expressed as means Ϯ S.E. Differences between the time curves were tested by analysis of variance using repeated measure design. p Ͻ 0.05 was considered to be statistically significant.
RESULTS
Identification of the Major in Vitro Phosphorylation
Site of PKC-in IRS-1-By developing a novel mass spectrometric approach for phosphopeptide screening out of complex phosphoprotein digest mixtures, we recently identified Ser 318 as a PKC-in vitro phosphorylation site in the IRS-1 N2 fragment (IRS-1 sequence from amino acid 265-522) (14) . To search for further in vitro PKC-phosphorylation sites in IRS-1 not covered by the N2-fragment, the PKC--catalyzed 32 P-incorporation in the NH 2 terminal 1 (IRS-1-N1), NH 2 terminal 2 (IRS-1-N2), the middle (IRS-1-M), and the C-terminal part (IRS-1-C) were compared ( Fig. 1, A and B) . Incubation of PKC-with N1, M, or C resulted in a low, essentially comparable 32 P-incorporation ( Fig. 1, A and B) . In contrast, we observed a 7-to 10-fold higher 32 P-incorporation in IRS-1 N2 (Fig. 1, A and B). The 32 P-incorporation of the GST part was negligible, because very little radioactivity remained in the GST part after thrombin cleavage of GST-IRS-1 N2 and subsequent gel-separation (data not shown).
The specificity of the PKC--mediated phosphorylation of Ser 318 of GST-IRS-1 N2 was studied by replacing the serine residue with alanine using site-directed mutagenesis (GSTAla 318 -IRS-1 N2 ). The HPLC elution profile of the tryptic digest of the wild-type GST-IRS-1 N2 contained a single major tryptic 32 P-labeled phosphopeptide, which was not present in the HPLC elution pattern of the GST-Ala 318 -IRS-1 N2 digest (Fig.  1C) . According to our previously published procedure (14) , mass spectrometric peptide sequencing revealed that more than 85% of total incorporated 32 P-radioactivity is based upon peaks of different variants of the monophosphorylated phospho-Ser 318 . Consequently, these peaks were not 32 P-phosphorylated in the HPLC-separated, mutated GST-Ala 318 -IRS-1 N2 digest. It is noteworthy that the pSer 318 containing tryptic peptide also contained the previously described Ser 307 phosphorylation site (10, (17) (18) (19) , but this was shown not to be phosphorylated by PKC-in either GST-Ser 318 IRS-1 N2 or GSTAla 318 -IRS-1 N2 using mass spectrometric analysis. Together, our in vitro results show that the IRS-1 N2 fragment is a preferred substrate for PKC-, and that Ser 318 is the preferential phosphorylation site in this IRS-1 fragment and possibly also in the whole IRS-1 molecule.
Phospho-site-specific Antibodies Demonstrate Insulin-stimulated and PKC--mediated Phosphorylation of Ser 318 in IRS-1-To determine whether the Ser 318 site is also phosphorylated by PKC-in living cells, a polyclonal antibody against a synthetic pSer 318 peptide was prepared. At first, the specificity of this antibody to detect IRS-1 phosphorylation on Ser 318 was evaluated by in vitro studies, which demonstrated that the PKC--phosphorylated wild-type GST-IRS-1 N2 but not the S318A mutated fragment was recognized by the pSer 318 antibody ( Fig. 2A) .
In BHK IR cells transiently transfected with wild-type IRS-1 stimulation with insulin for 60 min resulted in the observation of a specific band corresponding to immunoprecipitated IRS-1 after immunoblotting with pSer 318 antibody, whereas no signal was observed in the absence of insulin (Fig. 2B, left, lane 1) . Because PKC--mediated phosphorylation of IRS-1 has been shown to negatively regulate insulin signaling after 60 min of insulin-stimulation (6, 8), we used this condition for our experiments. Incubation of the cellular extracts with alkaline phosphatase or incubation at 37°C for 30 min without phosphatase inhibitors led to a complete loss of immunoreactivity of the antibody (data not shown), indicating that dephosphorylated IRS-1 is not recognized. Moreover, in BHK IR cells co-transfected with wild-type IRS-1 and PKC-, and in the absence of insulin, a signal of the phosphorylated Ser 318 was obtained, and this signal increased after 60 min of insulin stimulation (Fig. 2B, left, lanes 3 and 4) . Similarly, we observed a strong increase in insulin-stimulated Ser 318 immunoreactivity in HEK293 cells transiently co-transfected with wild-type IRS-1 and PKC-(data not shown). These results indicate that Ser 318 is strongly phosphorylated by PKC-after 60 min of insulin stimulation. Furthermore, the data show that insulin stimulates a kinase, probably endogenous PKC-, which phosphorylates IRS-1 at Ser 318 (Fig. 2B, left, lane 2) , and that transfected PKC-alone is also capable of phosphorylating Ser 318 in IRS-1 (Fig. 2B, left, lane 3) .
To IR cells which were transiently cotransfected with either IRS-1 wild type (wt) or S318A-IRS-1 (mut-318) and PKC-were stimulated with 100 nM insulin for 60 min. IRS-1 was immunoprecipitated with a monoclonal IRS-1 antibody (12H8) and immunoblotted with the phospho-site-specific Ser 318 antibody. The same blot was stripped and reprobed with a polyclonal IRS-1 antibody (sc560). C, immunoprecipitates of BHK IR cells which were transiently co-transfected with either IRS-1 wild type (wtϩPKC-) or S318A-IRS-1 (mut-318ϩPKC-) and PKC-were stimulated with 100 nM insulin for 2 and 60 min; immunoblot with the phospho-site-specific Ser 307 antibody and reprobe of the same blot with the polyclonal IRS-1 antibody (sc560). Representative results are shown from three experiments.
were transiently co-transfected with PKC-in BHK IR cells and stimulated with insulin for 60 min (Fig. 2B, right) . The mutated S318A-IRS-1 was only marginally recognized by the pSer 318 antibody, which is likely to be the result of the presence of endogenous wild-type IRS-1, whereas in the cells transfected with wild-type IRS-1, a strong immunocomplex with Ser 318 was seen. Both IRS-1 molecules were expressed to the same level, as shown by reblotting with a polyclonal IRS-1 antibody (Fig.  2B, right) . The Ser 318 antibody did not recognize the previously identified, insulin-dependent Ser 307 phosphorylation site, because the Ser 307 was phosphorylated in the mutated S318A-IRS-1, as demonstrated by the pSer 307 -specific antibody (Fig.  2C) . Moreover, Fig. 2C shows that insulin has a similar timedependent effect upon Ser 307 phosphorylation in cells with wild-type and S318A mutant forms of IRS-1, indicating that PKC--mediated Ser 318 phosphorylation does not influence insulin-stimulated Ser 307 . Furthermore, the pSer 307 antibody does not recognize pSer 318 in the GST-IRS-1 N2 fragment after in vitro PKC-phosphorylation (data not shown), indicating that both antibodies react specifically for their target pSer epitopes.
Phosphorylation of Ser 318 by PKC-under Prolonged Insulinstimulation Inhibits Complex Formation between IR and IRS-1 and Tyrosine Phosphorylation of IRS-1-To investigate whether PKC-phosphorylation of Ser
318 on IRS-1 inhibits the proximal insulin signaling, we studied the IRS-1 Ser 318 phosphorylation in BHK IR cells and compared it to the IRS-1 tyrosine phosphorylation stimulated at various time points with insulin (from 2 min to 60 min (prolonged)). Fig. 3, A and B shows a significant decrease in tyrosine phosphorylation after 60 min of insulin stimulation, whereas the Ser 318 phosphorylation increased to a plateau.
To confirm that prolonged insulin stimulation inhibits tyrosine phosphorylation of IRS-1 by promoting phosphorylation of Ser 318 by PKC-, we prepared BHK IR cells transiently expressing PKC-and either wild-type IRS-1 or mutated IRS-1 containing the S318A substitution. The results show that the increase in tyrosine phosphorylation of IRS-1 after 2 min was not significantly different in wild type and mutated IRS-1 (Fig.  3C) . However, after 60 min of insulin stimulation, cells transfected with mutated Ala 318 -IRS-1 showed no decrease in tyrosine phosphorylation of IRS-1, whereas cells transfected with the wild-type IRS-1 showed a significant reduction in IRS-1 tyrosine phosphorylation. The difference in the time course of the tyrosine phosphorylation between mutated and wild-type IRS-1 was statistically significant (p Ͻ 0.0005). In BHK IR cells incubated with 100 nM insulin and transfected either with wild-type IRS-1 or mutated Ala 318 -IRS-1 but without PKC-, no reduction of tyrosine phosphorylation of IRS-1 was observed after 60 min of insulin stimulation (data not shown), indicating that PKC-is necessary to obtain the insulin-stimulated reduction in tyrosine phosphorylation. Next, we investigated whether the PKC--mediated phosphorylation of Ser 318 of IRS-1 under prolonged insulin stimulation leads to a reduced complex formation between IR and IRS-1. The results show that in BHK IR cells overexpressing wild-type IRS-1 and PKC-, 60 min of insulin treatment resulted in an attenuated complex formation of IR/IRS-1 (Fig. 3D) , which is comparable with the effects recently shown in Fao cells by Liu et al. (6) . In contrast, complex formation was not altered under the same conditions when cells were co-transfected with the mutated Ala 318 -IRS-1 and PKC-(p Ͻ 0.005) (Fig. 3D) . Furthermore, in cells transfected with wild type or mutated IRS-1 but without PKC-, no attenuation of the complex formation was observed after 60 min of insulin treatment (data not shown), indicating that this effect is also PKC--dependent. These results are consistent with our hypothesis that the PKC--mediated phosphorylation of Ser 318 , which is closely located to the PTB domain of IRS-1, inhibits the interaction between the IR and IRS-1. Together, these results suggest that both the inhibition of the insulin-stimulated complex formation between IR and IRS-1 and the inhibition of the insulinstimulated tyrosine phosphorylation of IRS-1 are mediated, at least partially, by PKC--dependent phosphorylation of the Ser 318 of IRS-1.
Phosphorylation of Ser 318 by PKC-under Prolonged Insulinstimulation Did Not Attenuate the Tyrosine Phosphorylation of IRS-2-IRS-2
is structurally and functionally similar to IRS-1, and stimulation with insulin leads to the rapid tyrosine phosphorylation of both IRS-1 and IRS-2 (20, 21) . Therefore, we examined the correlation of PKC--induced IRS-1 Ser 318 phosphorylation with the insulin-stimulated tyrosine phosphorylation of IRS-2. As shown in Fig. 4A , the tyrosine phosphorylation of IRS-2 is not reduced by prolonged insulin treatment (60 min) in BHK IR cells overexpressing IRS-1, IRS-2, and PKC-, although the phosphorylation of the Ser 318 of IRS-1 is increased at all time points (Fig. 4B) . Moreover, in these cells expressing IRS-2, the phosphorylation of Ser 318 is also increased in the unstimulated state (Fig. 4B) . This apparently unexpected result may be explained by the recent report (22) that overexpression of IRS-2 leads to a constitutive increase in PKCactivity levels in L6hIR muscle cells. Thus, tyrosine phosphorylation of IRS-2 is not negatively regulated by Ser 318 phosphorylation of IRS-1 under prolonged insulin stimulation, in contrast to the inverse correlation of increased IRS-1 Ser 318 phosphorylation and decreased IRS-1 tyrosine phosphorylation after 60 min of insulin stimulation (shown in Fig. 3, A  and B) .
DISCUSSION
In the present study, we (i) identified Ser 318 as the major in vitro IRS-1 phosphorylation site of PKC-, (ii) generated and characterized a phospho-Ser 318 -specific antibody, and (iii) investigated the biological function of this phosphorylation site in BHK IR cells. The advantage of the in vitro approach is that the phosphorylation sites present in the amino acid sequence of the investigated protein are much easier to analyze because the protein is essentially pure and much more protein is available. Analysis of the phosphorylation of GST-tagged protein fragments of IRS-1 (molecular mass Ӎ 60 kDa) represents a good model for examination of PKC substrate specificity, assuming that these fragments are correctly folded. By using our in vitro experimental set-up, we detected only one major PKCphosphorylation site in the IRS-1 N2 fragment, although six consensus sites for PKC phosphorylation were predicted using the general consensus motif X-S/T-X-R/K (23). Moreover, our results further suggest that the other 10 potential phosphorylation consensus sites for the PKCs that are located in the other three IRS-1 fragments represent only minor phosphorylation sites. The situation, however, may be different in vivo because (i) the whole IRS-1 molecule may be differently folded, (ii) the intracellular environment is different, thus possibly affecting PKC-substrate specificity, and (iii) other kinases, in particular other PKC isoforms, may phosphorylate Ser 318 . To verify that Ser 318 is also phosphorylated in cells, a polyclonal antiserum against the peptide sequence surrounding phosphorylated Ser 318 in IRS-1 was prepared. Our experimental data demonstrate that it specifically recognizes the phosphorylated Ser 318 residue: it strongly immunoblots the in vitro PKC--phosphorylated wild-type IRS-1 N2 fragment but not the S318A mutated IRS-1 fragment. Again, in lysates from intact cells, the antibody strongly immunoblots IRS-1 immunoprecipitated from cells co-transfected with IRS-1 and PKC-after To investigate the biological relevance of this phosphorylation site, we first compared the Ser 318 phosphorylation of IRS-1 from acute (2 min) to prolonged (60 min) insulin stimulation with the tyrosine phosphorylation of IRS-1 and found an inverse correlation, indicating that Ser 318 phosphorylation precedes the down-regulation of tyrosine phosphorylation, i.e. inactivation of IRS-1. This effect seems to be specific for IRS-1, because IRS-2 tyrosine phosphorylation is not concomitantly decreased. However, our results also show that basal Ser 318 phosphorylation is influenced by IRS-2 expression, probably by means of the previously shown IRS-2-mediated PKC-activation (22) .
To further characterize the functional role of this site, Ser 318 was mutated to Ala. Although we observed no change after 2 min of insulin stimulation, the recently described reduction of IR/IRS-1 binding and IRS-1 tyrosine phosphorylation (3, 6, 8) was not observed after 60 min of insulin treatment in BHK IR cells transfected with the S318A-IRS-1 and PKC-. Because, after 2 min of insulin-stimulation, the alanine point mutation shows a normal complex formation between IR and IRS-1 and a normal tyrosine phosphorylation of IRS-1, site-directed mutagenesis does not obviously alter the structural integrity of IRS-1. Together, the results indicate that the presence of Ser 318 is necessary to obtain the reduced, PKC--mediated IR/IRS-1 complex formation and IRS-1 tyrosine phosphorylation after prolonged insulin-stimulation, effects which have been demonstrated previously in Fao cells (6) and in NIH3T3 IR fibroblasts (8) . Furthermore, it was shown that a kinase-inactive form of PKC-fails to mimic the inhibitory effects of its wild-type counterpart when transiently overexpressed in Fao or H-35 cells (6) and NIH3T3 IR cells (8) . In addition, it was shown that endogenous IRS-1 coprecipitates with endogenous PKC-, and this association is increased 2-fold upon insulin-stimulation, which further supports the finding that IRS-1 is a substrate for PKC- (6, 8) . Thus, PKC-might promote feedback inhibition of IR/IRS-1 complex formation and IRS-1 tyrosine phosphorylation through phosphorylation of Ser 318 without a negative regulatory effect on IRS-2 tyrosine phosphorylation. Based upon our findings in cells overexpressing IR, IRS-1, and/or IRS-2 and/or PKC-, future experiments in non-transfected, tissuespecific cells should be performed to confirm the importance and potential physiological relevance of our findings.
Extensive studies have provided evidence that phosphorylation of Ser 307 in IRS-1 inhibits IR/IRS-1 complex formation and IRS-1 tyrosine phosphorylation after prolonged insulin-stimulation similar to our results (10, (17) (18) (19) . However, this signaling pathway involves the activation of N-terminal Jun kinase. Furthermore, phosphorylation of Ser 307 may also be stimulated by tumor necrosis factor-␣ by means of a mitogen-activated protein-1-dependent pathway. These results, together with our findings, imply that insulin-stimulated activation of different kinases via differing pathways may lead to phosphorylation of either Ser 307 or Ser 318 in IRS-1 and that phosphorylation of either serine residue leads to attenuation of the proximal insulin signaling. Thus, the two distinct pathways might converge at this IRS-1 region (Ser 307 /Ser 318 ) and cause the inhibition of IRS-1 signaling.
The mechanism by which the phosphorylation of Ser 307 or Ser 318 inhibits IRS-1 tyrosine phosphorylation is not known. Prolonged insulin-stimulation inhibits IRS-1 binding to the phosphorylated NPEY motif in the juxta-membrane region of the IR ␤-subunit (9). Because Ser 307 or Ser 318 is adjacent to the PTB domain, its phosphorylation might disrupt the interaction between the phosphorylated NPEY motif of the IR and IRS-1. Although the PTB domain is not absolutely required for IRS-1 tyrosine phosphorylation, its presence strongly facilitates the process, and partial disruption of PTB domain function is expected to reduce coupling of IR to IRS-1 at endogenous levels of these proteins (24, 25) . Alternatively, phosphorylation of Ser A, for analysis of the tyrosine phosphorylation of IRS-2, 400 g of total protein were immunoprecipitated with anti-mouse IRS-2 rabbit antiserum and immunoblotted with the phospho-tyrosine-antibody (n ϭ 4). The membrane was reblotted with a commercial anti-IRS-2 (sc 06 -506) antibody. After 2 min of insulin-stimulation, the value of the mean was set as 100%. B, immunoblot with the phospho-site-specific Ser 318 antibody and reprobe of the same blot with the polyclonal IRS-1 antibody (sc560) is shown. Phospho-tyrosine and Ser 318 phosphorylation intensity were quantified based upon scanning densitometry of immunoblots normalized for IRS-1 and IRS-2 protein, respectively (n ϭ 4). sine phosphorylation by the insulin receptor kinase, while being subjected to the action of protein tyrosine phosphatases that reduce its phosphotyrosine content.
In summary, phosphorylation of Ser 318 is critical for the inhibitory effect of prolonged insulin-stimulation by PKC-in transfected cell lines, which might be mediated by the association of activated PKC-with IRS-1. Our results are consistent with the assumption that phospho-Ser 318 blocks the interaction between the IRS-1 PTB domain and the IR, which might significantly reduce the coupling between the activated IR and IRS-1. Based upon our findings in cells overexpressing insulin receptor, IRS-1, and/or PKC-, we hypothesize that the phosphorylation state of Ser 318 and other sites, e.g. Ser 307 , might predict, in certain cells or tissues, the ability of IRS-1 to mediate the insulin response.
